Multi-tiered intervention to increase maternal immunization coverage: A randomized, controlled trial

• Published in: Vaccine Vol. 40; no. 34; pp. 4955 - 4963
• Main Authors: Omer, Saad B., O'Leary, Sean T., Bednarczyk, Robert A., Ellingson, Mallory K., Spina, Christine I., Dudley, Matthew Z., Chamberlain, Allison T., Limaye, Rupali J., Brewer, Sarah E., Frew, Paula M., Malik, Fauzia A., Orenstein, Walter, Halsey, Neal, Ault, Kevin, Salmon, Daniel A.
• Format: Journal Article
• Language: English
• Published: Kidlington Elsevier Ltd 12-08-2022; Elsevier Limited
• Subjects: Clinics; Collaboration; Diphtheria; Electronic health records; Feedback; Immunization; Infections; Infectious diseases; Influenza; Intervention; Maternal immunization; Obstetrics; Participation; Pertussis; Pregnancy; Quality improvement; Risk management; Tetanus; Vaccine delivery; Vaccine uptake; Vaccines; Whooping cough; Womens health; United States > US; Colorado; Georgia; Pertussis; Quality improvement; Vaccine uptake; Maternal immunization; Vaccine delivery; Influenza
• ISSN: 0264-410X; 1873-2518
• DOI: 10.1016/j.vaccine.2022.06.055

To evaluate the impact of a multi-component intervention package of maternal immunization uptake in obstetric care clinics.
In a multi-level, cluster- and individually-randomized controlled trial we implemented an evidence-based intervention that targeted practice-, provider- and patient-level barriers to vaccine uptake. Obstetric practices were randomized to receive the practice and provider-level interventions or continue their normal standard of care. We enrolled pregnant women at practices in Georgia and Colorado and randomized women into patient-level intervention and control groups, resulting in four study arms. The primary outcomes were receipt of the influenza and tetanus, diphtheria and acellular pertussis (Tdap) vaccines during pregnancy. A sample size of 550 women per arm (2200 total) was planned and enrolled to compare the intervention between the four study arms.
Between June 2017 and July 2018, 4907 women were screened and 2200 women were randomized, 550 to each of the four study arms. We were unable to follow-up with 108 women, for a final sample size of 2092. Sample characteristics and sample size were similar among study arms. There was no significant increase in Tdap or influenza vaccine uptake overall. Among women who had no intention of or were unsure about receiving the influenza vaccine during pregnancy, those who received just the patient-level intervention were 61% more likely to receive the influenza vaccine than those in the control arm (Relative risk: 1.61; 95% Confidence Interval: 1.18–2.21). There was no significant difference in vaccine uptake for either influenza or tetanus, diphtheria and acellular pertussis between the four arms of the study.
This trial highlights the need for more targeted interventions to improve vaccine uptake. Future work should focus on clinics with low baseline vaccine uptake and the patient-level intervention should be expanded and targeted towards women with low vaccine confidence.